Applicant, as named in the Orange Book

Esperion Theraps Inc

Next listed expiry: Nexletol on 19 Jun 2040. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Nexletol bempedoic acid	bempedoic acid	211616	19 Jun 2040	patent
Nexlizet bempedoic acid; ezetimibe	bempedoic acid; ezetimibe	211617	19 Jun 2040	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.